In line with previous findings, this study also demonstrated that, upon treatment with BIBR1532, the PI3K/AKT/mTOR pathway was repressed, whereas the ERK1/2 MAPK pathway was activated in the MM cells. Here, AKT1 is linked to Miyoshi myopathy.